From: Differences in Menopausal Hormone Therapy Use among Women in Germany between 1998 and 2003
 | 1997–1999 survey | 2003–2004 survey | p-value |
---|---|---|---|
Sample size (unweighted total n) | 2284 (2248) | 2362 (2215) | Â |
Continuous variables, mean ± SD |  |  |  |
Age, years | 59.8 ± 12.0 | 60.0 ± 12.5 | 0.437 |
BMI, kg/m 2 | 27.8 ± 5.1 | 27.6 ± 5.2 | 0.566 |
Nominal and ordinal variables, n (%) | Â | Â | Â |
Residence in former West Germany | 1762(77.1) | 1841(77.9) | 0.515 |
Social status | Â | Â | Â |
   Lower | 691(31.8) | 848(36.9) | < 0.001 |
   Intermediate | 1115(51.4) | 1003(43.7) |  |
   Upper | 364(16.8) | 446(19.4) |  |
Smoking status | Â | Â | Â |
   Smoker | 405(18.4) | 485(20.5) | < 0.001 |
   Ex-smoker | 349(15.9) | 538(22.8) |  |
   Non-smoker | 1447(65.7) | 1339(56.7) |  |
Physical activity | Â | Â | Â |
   0 hrs/wk | 1277(58.4) | 1135(48.6) | < 0.001 |
   < 1 hrs/wk | 268(12.2) | 232(9.9) |  |
   1–2 hrs/wk | 377(17.2) | 503(21.5) |  |
   > 2 hrs/wk | 266(12.2) | 466(19.9) |  |
Pre-existing medical conditions (yes vs. no) | Â | Â | Â |
Diabetes | 217(9.6) | 228(9.7) | 0.891 |
Hypertension | 868(38.2) | 950(40.4) | 0.128 |
Hyperlipidemia | 751(33.0) | 881(37.5) | 0.001 |
CVD | 385(16.9) | 355(15.3) | 0.124 |
Current MHT use # , n (%) | 386(16.9) | 238(10.1) | < 0.001 |
   ≤ 1 year (new starters) | 71(3.1) | 16(0.7) | < 0.001 |
   1–3 years | 81(3.5) | 31(1.3) | < 0.001 |
   > 3 years (long-term users) | 230(10.1) | 189(8.0) | 0.014 |